Registry Study for Personalized Cancer Therapy

CompletedOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

July 21, 2015

Primary Completion Date

July 10, 2020

Study Completion Date

July 10, 2020

Conditions
Advanced CancersSolid Tumors
Interventions
OTHER

Review of Screening Tests and Molecular Test Results

Review of screening tests and molecular test results in participant's medical records. Study staff and study doctor work together to find an off-label use for an FDA approved therapy that is best for participant.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT02508662 - Registry Study for Personalized Cancer Therapy | Biotech Hunter | Biotech Hunter